When Nigeria and Kenya confirmed Ebola this month, officials stressed one detail: the virus is Bundibugyo. That matters, because the tools that helped end recent outbreaks were built for a different species.
The Ebola family
“Ebola” covers several related viruses. Four cause disease in people. The best known are Zaire ebolavirus, behind the 2014–2016 West Africa epidemic, which included the Lagos cases, and most DR Congo outbreaks; Sudan ebolavirus; and Bundibugyo ebolavirus, first identified in 2007 in Bundibugyo district, Uganda.
Key differences
| Zaire | Bundibugyo | |
|---|---|---|
| Licensed vaccine | Yes (Ervebo) | No |
| Approved antibody treatments | Yes | No |
| Past outbreaks | Many, including 2014–2016 West Africa | Uganda 2007, DR Congo 2012, and now 2026 |
| Historical fatality | Often highest of the species | Lower in past outbreaks (roughly a third of cases), but still severe |
| Spread and symptoms | The same: contact with body fluids; fever, weakness, vomiting, diarrhoea, sometimes bleeding | |
What it means for nurses
- There is no vaccine to protect you, so PPE, early isolation and infection prevention are your only defences.
- Supportive care decides survival. Fluids, electrolytes and treatment of other infections and complications all make a real difference.
- Researchers are testing candidate vaccines and treatments in trials. Any use outside a trial follows national and WHO decisions.
Related: Ebola signs, symptoms and nursing care · Ebola PPE guide
Sources: WHO Ebola fact sheet; Al Jazeera (21 October 2026); AP (17 October 2026). Educational content.



Leave a Reply